<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Purinergic Signal</journal-id>
      <journal-title>Purinergic Signalling</journal-title>
      <issn pub-type="ppub">1573-9538</issn>
      <issn pub-type="epub">1573-9546</issn>
      <publisher>
        <publisher-name>Springer Netherlands</publisher-name>
        <publisher-loc>Dordrecht</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18404448</article-id>
      <article-id pub-id-type="pmc">2072912</article-id>
      <article-id pub-id-type="publisher-id">9060</article-id>
      <article-id pub-id-type="doi">10.1007/s11302-007-9060-4</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Paper</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>[<sup>3</sup>H]Adenine is a suitable radioligand for the labeling of G protein-coupled adenine receptors but shows high affinity to bacterial contaminations in buffer solutions</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Schiedel</surname>
            <given-names>Anke C.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Meyer</surname>
            <given-names>Heiko</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Alsdorf</surname>
            <given-names>Bernt B.A.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gorzalka</surname>
            <given-names>Simone</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Br&#xFC;ssel</surname>
            <given-names>Hannelore</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>M&#xFC;ller</surname>
            <given-names>Christa E.</given-names>
          </name>
          <address>
            <phone>+49-228-732301</phone>
            <fax>+40-228-732567</fax>
            <email>christa.mueller@uni-bonn.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>University of Bonn, Pharmaceutical Institute, Pharmaceutical Sciences Bonn (PSB), Pharmaceutical Chemistry I, Bonn, Germany </aff>
        <aff id="Aff2"><label>2</label>University of Bonn, Institute of Animal Science, Physiology &amp; Hygiene Group, Bonn, Germany </aff>
        <aff id="Aff3"><label>3</label>Pharmazeutisches Institut, Pharmazeutische Chemie I, An der Immenburg 4, 53121 Bonn, Germany </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>7</month>
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2007</year>
      </pub-date>
      <volume>3</volume>
      <issue>4</issue>
      <fpage>347</fpage>
      <lpage>358</lpage>
      <history>
        <date date-type="received">
          <day>3</day>
          <month>6</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>6</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Springer Science + Business Media B.V. 2007</copyright-statement>
      </permissions>
      <abstract>
        <p>[<sup>3</sup>H]Adenine has previously been used to label the newly discovered G protein-coupled murine adenine receptors. Recent reports have questioned the suitability of [<sup>3</sup>H]adenine for adenine receptor binding studies because of curious results, e.g. high specific binding even in the absence of mammalian protein. In this study, we showed that specific [<sup>3</sup>H]adenine binding to various mammalian membrane preparations increased linearly with protein concentration. Furthermore, we found that Tris-buffer solutions typically used for radioligand binding studies (50&#xA0;mM, pH 7.4) that have not been freshly prepared but stored at 4&#xB0;C for some time may contain bacterial contaminations that exhibit high affinity binding for [<sup>3</sup>H]adenine. Specific binding is abolished by heating the contaminated buffer or filtering it through 0.2-&#x3BC;m filters. Three different, aerobic, gram-negative bacteria were isolated from a contaminated buffer solution and identified as <italic>Achromobacter xylosoxidans</italic>, <italic>A. denitrificans</italic>, and <italic>Acinetobacter lwoffii</italic>. <italic>A. xylosoxidans</italic>, a common bacterium that can cause nosocomial infections, showed a particularly high affinity for [<sup>3</sup>H]adenine in the low nanomolar range. Structure&#x2013;activity relationships revealed that hypoxanthine also bound with high affinity to <italic>A. xylosoxidans</italic>, whereas other nucleobases (uracil, xanthine) and nucleosides (adenosine, uridine) did not. The nature of the labeled site in bacteria is not known, but preliminary results indicate that it may be a high-affinity purine transporter. We conclude that [<sup>3</sup>H]adenine is a well-suitable radioligand for adenine receptor binding studies but that bacterial contamination of the employed buffer solutions must be avoided.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>
          <italic>Achromobacter</italic>
        </kwd>
        <kwd>
          <italic>Acinetobacter</italic>
        </kwd>
        <kwd>Adenine receptor</kwd>
        <kwd>Bacterial buffer contamination</kwd>
        <kwd>G protein-coupled receptor</kwd>
        <kwd>Nosocomial infection</kwd>
        <kwd>Purine transporter</kwd>
        <kwd>Purinergic receptor</kwd>
        <kwd>Radioligand binding studies</kwd>
        <kwd>[<sup>3</sup>H]adenine</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media B.V. 2007</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>Purinergic receptors play an important role in transmembrane signaling [<xref ref-type="bibr" rid="CR1">1</xref>]. Currently, two distinct families are officially recognized by the International Union of Pharmacology (IUPHAR), i.e. receptors for the purine nucleoside adenosine (P1 or adenosine receptors) and receptors for purine and/or pyrimidine nucleotides (P2 receptors) [<xref ref-type="bibr" rid="CR2">2</xref>&#x2013;<xref ref-type="bibr" rid="CR4">4</xref>]. Whereas the P1 receptor family comprises four subtypes, A<sub>1</sub>, A<sub>2A</sub>, A<sub>2B</sub>, and A<sub>3</sub>, all of which are G protein-coupled receptors (GPCRs), the P2 family is further subdivided into two subfamilies, P2Y (GPCRs) and P2X (ligand-gated ion channels) [<xref ref-type="bibr" rid="CR2">2</xref>&#x2013;<xref ref-type="bibr" rid="CR4">4</xref>]. In addition to the nucleoside (adenosine) and nucleotide receptors, a receptor for the nucleobase adenine has recently been discovered by a reverse pharmacological approach identifying adenine as the natural ligand for a rat orphan GPCR [<xref ref-type="bibr" rid="CR5">5</xref>]. A mouse orthologue (mMrgA10) of the rat adenine receptor was subsequently identified by sequence comparison [<xref ref-type="bibr" rid="CR5">5</xref>]. Very recently, a new adenine receptor has been cloned from mice showing 82% identity in its amino acid sequence to mMrgA10 and 76% to the rat adenine receptor, indicating that the new receptor is a distinct adenine receptor subtype (Genbank nucleotide sequence accession numbers: new mouse adenine receptor, DQ386867; mMrgA10, XM_195647; rat adenine receptor, AJ311952) [<xref ref-type="bibr" rid="CR6">6</xref>, submitted]. Both adenine receptors that have been pharmacologically characterized are coupled to the inhibition of adenylate cyclase by G<sub>i</sub> protein [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. So far, no human receptor for adenine has been identified, although initial clues for the possible existence of human adenine receptors have been found [<xref ref-type="bibr" rid="CR7">7</xref>]. Adenine receptors are structurally unrelated to P1 and P2 receptors and therefore constitute a new family of purinergic receptors for which we proposed the designation P0 (&#x201C;P zero&#x201D;) receptors [<xref ref-type="bibr" rid="CR8">8</xref>] based on the structural relationships of the physiological agonists, adenine (P0) representing a partial structure of adenosine (P1) and adenosine again being a partial structure of adenine nucleotides (P2), such as adenosine triphosphate (ATP) or adenosine diphosphate (ADP).</p>
      <p>Radioligand binding studies are widely used to characterize GPCRs on the protein level [<xref ref-type="bibr" rid="CR9">9</xref>]. Adenine, the natural ligand of adenine receptors, is commercially available in tritium-labeled form ([<sup>3</sup>H]adenine) and has been used to characterize recombinant rat adenine receptors expressed in Chinese hamster ovary (CHO) cells [<xref ref-type="bibr" rid="CR5">5</xref>] as well as natively expressed rat adenine receptors in rat brain [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR10">10</xref>] using membrane preparations. The radioligand has been shown to be stable under the incubation conditions [<xref ref-type="bibr" rid="CR10">10</xref>]. Furthermore, mouse adenine receptors natively expressed in NG108-15 (neuroblastoma &#xD7; glioma hybrid) cell membranes were labeled by [<sup>3</sup>H]adenine [<xref ref-type="bibr" rid="CR7">7</xref>]. Recently, we successfully applied [<sup>3</sup>H]adenine binding to detect the mouse adenine receptor protein recombinantly expressed in Sf21 insect cell membranes, which constitute a null background because they do not endogenously express any high affinity binding site for adenine [<xref ref-type="bibr" rid="CR6">6</xref>].</p>
      <p>Two recent poster presentations reported on problems with [<sup>3</sup>H]adenine binding to adenine receptors. In one study using whole rat brain membrane preparations, a high-affinity binding site was detected (apparent K<sub>i</sub> 57.5&#xA0;nM) [<xref ref-type="bibr" rid="CR11">11</xref>]. However, a very high B<sub>max</sub> value was found (281&#xA0;pmol/mg protein), and the binding was almost completely blocked by 10&#xA0;&#x3BC;M of hypoxanthine and abolished in the absence of Mg<sup>2+</sup>, indicating that the detected binding site was not identical with the G protein-coupled rat adenine receptor [<xref ref-type="bibr" rid="CR11">11</xref>]. In another study, high affinity binding of [<sup>3</sup>H]adenine was detected even in the absence of added protein, and the authors suggested that [<sup>3</sup>H]adenine bound in a highly specific manner to the glass fiber filters used in the filtration assays [<xref ref-type="bibr" rid="CR12">12</xref>]. IC<sub>50</sub> values were determined for five adenine derivatives and three compounds [adenine (18&#xA0;nM [<xref ref-type="bibr" rid="CR12">12</xref>]; rat: 29.9&#xA0;nM [<xref ref-type="bibr" rid="CR7">7</xref>], 18&#xA0;nM [<xref ref-type="bibr" rid="CR5">5</xref>]), 7-ethyladenine (30&#xA0;&#x3BC;M [<xref ref-type="bibr" rid="CR12">12</xref>]; rat: 47.3&#xA0;&#x3BC;M [<xref ref-type="bibr" rid="CR7">7</xref>]), 8-bromoadenine (14&#xA0;&#x3BC;M [<xref ref-type="bibr" rid="CR12">12</xref>]; rat: 17.3&#xA0;&#x3BC;M [<xref ref-type="bibr" rid="CR7">7</xref>]] showed similar IC<sub>50</sub> values as those previously determined for the rat adenine receptor, but two compounds [5&#x2032;-deoxyadenosine (725&#xA0;&#x3BC;M [<xref ref-type="bibr" rid="CR12">12</xref>]; rat: 0.823&#xA0;&#x3BC;M [<xref ref-type="bibr" rid="CR10">10</xref>]), 2-fluoroadenosine (19&#xA0;&#x3BC;M [<xref ref-type="bibr" rid="CR12">12</xref>]; rat: 0.62&#xA0;&#x3BC;M [<xref ref-type="bibr" rid="CR7">7</xref>]] had much lower affinities for the unknown binding site labeled in the absence of added protein [<xref ref-type="bibr" rid="CR12">12</xref>] than for the rat adenine receptor as previously determined [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR10">10</xref>], indicating that the unknown binding sites labeled in the absence of added rat tissue were very different. Based on their results, the IJzerman group had suggested to avoid the use of [<sup>3</sup>H]adenine as a radiolabeled probe for the adenine receptor due to its putative specific, high-affinity binding to glass fiber filters [<xref ref-type="bibr" rid="CR12">12</xref>].</p>
      <p>That report prompted us to carefully reanalyze radioligand binding data obtained with [<sup>3</sup>H]adenine in our laboratory with the goal to find out the reason for the problems encountered in other laboratories. As a matter of fact, we had occasionally observed unusually high counts in a few experiments, which could, however, be avoided by repeating the experiments under carefully controlled experimental conditions, including the use of freshly prepared buffer solutions. We have now performed a systematic study clearly showing that [<sup>3</sup>H]adenine is a suitable radioligand for the labeling of adenine receptors in various cells and tissues if bacterial contaminations are excluded. Furthermore, we identified three common gram-negative aerobic bacteria that grow in cold Tris buffer and express high-affinity binding sites for [<sup>3</sup>H]adenine.</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Materials and methods</title>
      <sec id="Sec3">
        <title>Chemicals</title>
        <p>[8-<sup>3</sup>H]Adenine (27&#xA0;Ci/mmol) was obtained from Amersham Biosciences (Munich, Germany). Tris was obtained from Acros Organics (Leverkusen, Germany) and dimethyl sulfoxide (DMSO) was from Fluka (Switzerland). All other chemicals and reagents were obtained from Sigma unless otherwise noted.</p>
      </sec>
      <sec id="Sec4">
        <title>Cell culture</title>
        <p>Human embryonic kidney (HEK) 293 and CHO-K1 cells were grown as monolayers at 37&#xB0;C (5% CO<sub>2</sub>) in Dulbecco&#x2019;s modified Eagle medium (DMEM) containing 10% fetal calf serum, 100 U/ml penicillin, 100&#xA0;&#x3BC;g/ml streptomycin, and 2&#xA0;mM L-glutamine.</p>
      </sec>
      <sec id="Sec5">
        <title>Membrane preparations</title>
        <p>Frozen rat brains were obtained from Pel Freez (Rogers, AR, USA) and thawed at 4&#xB0;C. Cortex and striata were dissected, and membrane fractions were prepared as previously described [<xref ref-type="bibr" rid="CR7">7</xref>]. Membrane preparations from CHO-K1 cells, and HEK293 cells were prepared as described [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Membrane preparations from bacteria were obtained after growing them on agar plates and subsequent amplification of single strains in Lennox broth (LB) medium over night. Membranes were then prepared in analogy to the procedures used for mammalian-cell membranes [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Protein concentrations were determined according to the method of Lowry [<xref ref-type="bibr" rid="CR15">15</xref>].</p>
      </sec>
      <sec id="Sec6">
        <title>[<sup>3</sup>H]Adenine binding assays</title>
        <p>Adenine binding assays were carried out as previously described [<xref ref-type="bibr" rid="CR7">7</xref>]; however, in the absence of Mg<sup>2+</sup> and ethyleneglycoltetraacetic acid (EGTA), unless otherwise noted, as Mg<sup>2+</sup> and EGTA were found to have no effect on determined K<sub>i</sub> values (data not shown). In brief, membrane preparations (50&#xA0;&#x3BC;g of protein, unless otherwise indicated) were incubated with 10&#xA0;nM [<sup>3</sup>H]adenine in 50&#xA0;mM Tris-HCl, pH 7.4 in a total volume of 200&#xA0;&#x3BC;l. Inhibition curves were determined using six to nine different concentrations of adenine, spanning three orders of magnitude. Three separate experiments were performed, each in triplicate, unless otherwise noted. Nonspecific binding was determined in the presence of 100&#xA0;&#x3BC;M unlabeled adenine. Incubations were carried out for 1&#xA0;h at room temperature and terminated by rapid filtration through GF/B glass fiber filters (Whatman, Dassel, Germany). Filters were washed three times, 2&#xA0;ml each, with freshly prepared ice-cold 50&#xA0;mM Tris-HCl buffer, pH 7.4 and immediately transferred to mini vials. Scintillation cocktail (Ultima Gold, Canberra Packard, 2.5&#xA0;ml) was added and after an incubation of 9&#xA0;h filter-bound radioactivity was measured by liquid scintillation counting at an efficiency of 54%. In some experiments, the addition of mammalian protein was omitted and replaced by 100&#xA0;&#x3BC;l of different buffer samples. For competition experiments with bacteria, either 100&#xA0;&#x3BC;l of 1:100 or 1:1000 dilution of an overnight culture of the bacteria in Tris buffer, 50&#xA0;mM, pH 7.4, or a membrane preparation of bacteria (containing 0.4&#x2013;10&#xA0;&#x3BC;g of protein) was used.</p>
        <p>After isolation and classification of the bacteria from contaminated buffer solutions, experiments were performed with intact bacteria (approximately 6&#x2009;&#xD7;&#x2009;10<sup>4</sup> bacteria/sample, which roughly equals 0.5&#xA0;&#x3BC;g of total protein/sample), unless otherwise indicated, using the standard procedure (see above). The cell number was estimated from the optical density (OD) of the overnight culture suspension, and the assumption that <inline-formula id="IEq1"><!-- Alternate image not processed: 11302_2007_9060_Article_IEq1.gif --><tex-math id="M1">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{OD}}_{{600}}  = 1\;{\text{equals}}\;3 \times 10^{8} \;{{\text{cells}}} \mathord{\left/  {\vphantom {{{\text{cells}}} {{\text{ml}}}}} \right.  \kern-\nulldelimiterspace} {{\text{ml}}} $$\end{document}</tex-math></inline-formula> [<xref ref-type="bibr" rid="CR16">16</xref>].</p>
      </sec>
      <sec id="Sec7">
        <title>Data analysis</title>
        <p>Data were analyzed using Prism 4.03 (Graph Pad, San Diego, CA, USA). IC<sub>50</sub> values were determined by fitting data to sigmoidal concentration-inhibition curves. Results are presented as means &#xB1; standard error of the mean (SEM) from the number of observations.</p>
      </sec>
      <sec id="Sec8">
        <title>Isolation of microorganisms from contaminated buffer solutions and classification</title>
        <p>Microorganisms were isolated from Tris-HCl buffer, pH 7.4, by plating 300&#xA0;&#x3BC;l of the buffer on LB agar plates. Single colonies were isolated and incubated overnight in LB medium at 37&#xB0;C with constant shaking at 230&#xA0;rpm. Further separation was achieved by plating bacteria from overnight cultures on plate count (Merck, Darmstadt) and blood agar (Oxoid, Wesel). Morphology of colonies was visually examined. Conventional physiological and biochemical characterization assays, including gram staining, catalase and oxidase activity, motility, and oxidation/fermentation (O/F) test were carried out and analyzed according to <italic> Bergey&#x2019;s Manual of Systematic Bacteriology</italic> using reagents from Merck (Darmstadt) [<xref ref-type="bibr" rid="CR17">17</xref>]. In addition, the following kits and appliances were used: BBL OXI/FERM Tube II (Schwarz Pharma GmbH, Germany), API 20 NE strips and apiweb software (Biomerieux, N&#xFC;rtingen, Germany), and VITEK 2 fully automated system (Biomerieux, N&#xFC;rtingen, Germany).</p>
      </sec>
    </sec>
    <sec id="Sec9" sec-type="results">
      <title>Results</title>
      <sec id="Sec10">
        <title>Protein dependence of [<sup>3</sup>H]adenine binding</title>
        <p>As a first step, we reevaluated (unpublished) data obtained in initial studies that had been performed to investigate the suitability of [<sup>3</sup>H]adenine as a radioligand for labeling adenine receptors. Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref> shows [<sup>3</sup>H]adenine binding to different membrane preparations from (a) rat brain striatum, (b) rat brain cortex, and (c) HEK293 cells and CHO-K1 cells. For each membrane preparation, different amounts of protein were investigated (25, 50, 100, and 200&#xA0;&#x3BC;g for striatum; 0, 25, 50, 100, and 200&#xA0;&#x3BC;g for cortex; 50 and 100&#xA0;&#x3BC;g for HEK and CHO cells). In all cases, we found a large, approximately linear, increase in specific binding with increasing protein concentration, whereas the increase in nonspecific binding was small. No specific binding was detected in the absence of protein (see Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>b).
<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Protein dependence of [<sup>3</sup>H]adenine binding to adenine receptors in rat brain striatal membranes (<bold>a</bold>), in rat brain cortical membranes (<bold>b</bold>), and in human embryonic kidney (HEK293) cell membranes and in Chinese hamster ovary cell (CHO) membranes (<bold>c</bold>). Different amounts of protein were incubated for 60&#xA0;min with 10&#xA0;nM of [<sup>3</sup>H]adenine in Tris-HCl buffer, pH 7.4 (<italic>n</italic>&#x2009;=&#x2009;3). Nonspecific binding was determined in the presence of 100&#xA0;&#x3BC;M adenine</p></caption><graphic position="anchor" xlink:href="11302_2007_9060_Fig1_HTML" id="MO1"/></fig></p>
      </sec>
      <sec id="Sec11">
        <title>Microbial contaminations in buffer solutions</title>
        <p>As a next step, we investigated whether microbial contaminations present in incubation buffers that were not freshly prepared might be responsible for high counts occasionally observed in [<sup>3</sup>H]adenine binding studies in our laboratory. We performed a systematic analysis of buffer solutions (50&#xA0;mM Tris-HCl, pH 7.4) stored at different conditions (different periods of time and temperatures), in different containers (plastic, glass, different sizes) used in our laboratory. Samples of buffer solutions were taken, and radioligand binding studies were performed with [<sup>3</sup>H]adenine (10&#xA0;nM) using the same procedure as for the labeling of adenine receptors, except that no tissue or cell membrane preparation was added. Most investigated buffer solutions did not show any specific [<sup>3</sup>H]adenine binding. However, one sample of Tris buffer that had been taken from a 5-l plastic container with a small orifice, stored at 4&#xB0;C, exhibited high affinity binding of [<sup>3</sup>H]adenine (data not shown). In contrast, radioligands used for the labeling of adenosine receptors ([<sup>3</sup>H]2-Chloro-N<sup>6</sup>-[<sup>3</sup>H]cyclopentyladenosine (CCPA) (A<sub>1</sub>) [<xref ref-type="bibr" rid="CR18">18</xref>], [<sup>3</sup>H][<sup>3</sup>H]3-(3-hydroxypropyl)-7-methyl-8-(<italic>m</italic>-methoxystyryl)-1-propargylxanthine (MSX)-2 (A<sub>2A</sub>) [<xref ref-type="bibr" rid="CR19">19</xref>], [<sup>3</sup>H]8-Ethyl-4-methyl-2-phenyl-(8<italic>R</italic>)-4,5,7,8-tetrahydro-1<italic>H</italic>-imidazo[2,1 ]purin-5-one (PSB)-11 (A<sub>3</sub>) [<xref ref-type="bibr" rid="CR20">20</xref>]), or P2Y<sub>12</sub> receptors ([<sup>3</sup>H]2-propylthioadenosine-5&#x2032;-adenylic acid (1,1-dichloro-1-phosphonomethyl-1-phosphonyl) anhydride (PSB)-0413) [<xref ref-type="bibr" rid="CR21">21</xref>] did not show any specific binding to that buffer solution.</p>
        <p>Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref> shows [<sup>3</sup>H]adenine binding determined in differently treated Tris-buffer solutions (in the absence of added protein). Freshly prepared buffer did not show any specific [<sup>3</sup>H]adenine binding. After storing the buffer for 1 day at 4&#xB0;C, a small degree of [<sup>3</sup>H]adenine binding could be observed, and after 2 weeks, [<sup>3</sup>H]adenine binding was significant (562&#x2009;&#xB1;&#x2009;19&#xA0;cpm specific binding). There was a large, exponential increase in specific [<sup>3</sup>H]adenine binding with time, and after 6&#xA0;weeks at 4&#xB0;C, approximately 7,000&#xA0;cpm (specific binding) were measured. After the 6-week-old buffer was filtered through 0.2&#xA0;&#x3BC;m filters, [<sup>3</sup>H]adenine binding was completely abolished. Heating of the buffer for 1&#xA0;min at 80&#xB0;C dramatically reduced [<sup>3</sup>H]adenine binding, whereas heating for 3&#xA0;min at 80&#xB0;C or heating at 121&#xB0;C for 20&#xA0;min in an autoclave led to complete loss of specific [<sup>3</sup>H]adenine binding.
<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>[<sup>3</sup>H]Adenine binding in the absence of added protein (cells or cell membranes). Incubation buffer (Tris-HCl, pH 7.4) was kept in a 5-l plastic container at 4&#xB0;C for up to 6&#xA0;weeks. Differently treated buffer samples (100&#xA0;&#x3BC;l) were tested for [<sup>3</sup>H]adenine binding. The results shown represent means of three independent experiments &#xB1; standard error of the mean</p></caption><graphic position="anchor" xlink:href="11302_2007_9060_Fig2_HTML" id="MO2"/></fig></p>
      </sec>
      <sec id="Sec12">
        <title>Isolation of microbial buffer contaminants</title>
        <p>As our results indicated that adenine binding was due to microbial contaminations growing in the incubation buffer, we decided to isolate the contaminants in order to characterize and eventually identify them. The microorganisms were isolated by plating contaminated incubation buffer on agar plates. This led to identification of three bacterial strains differing in the morphology of the formed colonies. The three strains were then separately amplified in medium over night, and membrane preparations were obtained to perform homologous competition binding assays using [<sup>3</sup>H]adenine (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>a).
<fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Competition curves for adenine versus 10&#xA0;nM [<sup>3</sup>H]adenine obtained with membrane preparations from rat brain cortex and isolated microorganisms (contaminants 1&#x2013;3) (<bold>a</bold>) and intact bacteria (<bold>b</bold>). IC<sub>50</sub> values (<bold>a</bold>): <inline-formula id="IEq2"><!-- Alternate image not processed: 11302_2007_9060_Article_IEq2.gif --><tex-math id="M2">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$${\text{rat}}\,{\text{cortex}} = 57.0 \pm 4.4\;{\text{nM}}{\left( {n = 3} \right)}$$\end{document}</tex-math></inline-formula>; <inline-formula id="IEq3"><!-- Alternate image not processed: 11302_2007_9060_Article_IEq3.gif --><tex-math id="M3">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$${\text{contaminant}}\;1 = 4.59 \pm 0.49\;{\text{nM}}{\left( {n = 3} \right)}$$\end{document}</tex-math></inline-formula>; <inline-formula id="IEq4"><!-- Alternate image not processed: 11302_2007_9060_Article_IEq4.gif --><tex-math id="M4">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$${\text{contaminant}}\;2 = 1,010 \pm 240\;{\text{nM}}{\left( {n = 2} \right)}$$\end{document}</tex-math></inline-formula>; contaminant 3&#x2009;=&#x2009;2,350&#xA0;nM, (<italic>n</italic>&#x2009;=&#x2009;1). IC<sub>50</sub> values (<bold>b</bold>): <inline-formula id="IEq5"><!-- Alternate image not processed: 11302_2007_9060_Article_IEq5.gif --><tex-math id="M5">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$Achromobacter\,xylosoxidans = 13.8 \pm 2.7\;{\text{nM}}{\left( {n = 8} \right)}$$\end{document}</tex-math></inline-formula>; <inline-formula id="IEq6"><!-- Alternate image not processed: 11302_2007_9060_Article_IEq6.gif --><tex-math id="M6">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$Achromobacter\,denitrificans = 253 \pm 46\;{\text{nM}}{\left( {n = 5} \right)}$$\end{document}</tex-math></inline-formula>; <inline-formula id="IEq7"><!-- Alternate image not processed: 11302_2007_9060_Article_IEq7.gif --><tex-math id="M7">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$Acinetobacter\,lwoffii = 299 \pm 129\;{\text{nM}}{\left( {n = 5} \right)}$$\end{document}</tex-math></inline-formula></p></caption><graphic position="anchor" xlink:href="11302_2007_9060_Fig3_HTML" id="MO3"/></fig></p>
        <p>Membrane preparations of contaminant 1 showed a very high affinity for adenine (<inline-formula id="IEq8"><!-- Alternate image not processed: 11302_2007_9060_Article_IEq8.gif --><tex-math id="M8">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{IC}}_{{50}}  = 4.59 \pm 0.49\;{\text{nM}}\;{\text{vs}}{\text{.}}\;10\;{\text{nM}}\;{\left[ {^{3} {\text{H}}} \right]}{\text{adenine}} $$\end{document}</tex-math></inline-formula>,<italic> n</italic>&#x2009;=&#x2009;3), whereas membrane preparations of the other two contaminants appeared to have considerably lower affinities (contaminant 2: <inline-formula id="IEq9"><!-- Alternate image not processed: 11302_2007_9060_Article_IEq9.gif --><tex-math id="M9">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{IC}}_{{50}}  = 1008 \pm 240\;{\text{nM}} $$\end{document}</tex-math></inline-formula>,<italic> n</italic>&#x2009;=&#x2009;2; contaminant 3: IC<sub>50</sub>&#x2009;=&#x2009;2351&#xA0;nM,<italic> n</italic>&#x2009;=&#x2009;1). For comparison, the binding curve for adenine at rat brain cortical adenine receptors (<inline-formula id="IEq10"><!-- Alternate image not processed: 11302_2007_9060_Article_IEq10.gif --><tex-math id="M10">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{IC}}_{{50}}  = 57.0 \pm 4.4\;{\text{nM}} $$\end{document}</tex-math></inline-formula>) is shown (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>a). Using amounts of membrane preparations of contaminant 1 that contained more than 1 &#x3BC;g protein/assay tube led to depletion of the radioligand (more than 50% of the added radioligand was bound to the protein) (data not shown).</p>
      </sec>
      <sec id="Sec13">
        <title>Identification of microbial contaminants</title>
        <p>In order to identify the contaminants, standard procedures and classification kits were used (see Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). Standard tests, including catalase, oxidase, fermentation, motility test, and gram staining indicated that contaminant 1 is <italic>Pseudomonas </italic> spp. or a strain of <italic>Achromobacter</italic> spp., contaminant 2 is <italic>Achromobacter </italic> spp., and contaminant 3 <italic>Acinetobacter </italic>spp. [<xref ref-type="bibr" rid="CR17">17</xref>]. All three bacteria are strictly aerobic gram-negative rods. For further classification, a standardized system (Api 20 NE) for classification of bacteria was used, which combines conventional and assimilation tests for identification of gram-negative rods not belonging to the Enterobacteriaceae. It was found that contaminant 1 was positive for oxidase, nitrate reduction, glucose degradation, gluconate, caprate, adipate, maltose, citrate, and phenylacetate, whereas contaminant 2 was negative for glucose, and caprate and contaminant 3 only showed positive results for caprate, maltose, and phenylacetate. Those results confirmed contaminant 3, already presumed to belong to the species <italic>Acinetobacter</italic>, as <italic>A. lwoffii</italic>, with a probability of 98.1%, and led to the identification of contaminant 1 as <italic>A. xylosoxidans</italic> (94.5% probability) and of contaminant 2 as <italic>A. denitrificans</italic> (82.2% probability) (see Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). Identification of the two <italic>Achromobacter</italic> strains with the VITEK fully automated system for rapid bacterial identification and antibiotic susceptibility confirmed both as members of the <italic>Achromobacter</italic> spp. with a probability of 90% each; however, differences were found in the results for phosphate, citrate, and proline assimilation (for details, see Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref> summarizes selected test results, which were positive for at least one of the strains.
<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Summary of classification test results using standard procedures and kits</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Test</th><th>Contaminant 1</th><th>Contaminant 2</th><th>Contaminant 3</th></tr></thead><tbody><tr><td colspan="4">Morphology of colonies</td></tr><tr><td>&#xA0;&#xA0;Form</td><td>Round</td><td>Round</td><td>Round</td></tr><tr><td>&#xA0;&#xA0;Diameter</td><td>1&#x2013;2&#xA0;mm</td><td>1&#xA0;mm</td><td>1&#xA0;mm</td></tr><tr><td>&#xA0;&#xA0;Color</td><td>Grey</td><td>Beige</td><td>White</td></tr><tr><td>&#xA0;&#xA0;Brim</td><td>Smooth</td><td>Smooth</td><td>Smooth</td></tr><tr><td>&#xA0;&#xA0;Surface</td><td>Shiny</td><td>Shiny</td><td>Shiny</td></tr><tr><td>&#xA0;&#xA0;Cross section</td><td>Raised</td><td>Raised</td><td>Raised</td></tr><tr><td>&#xA0;&#xA0;Gram stain</td><td>Negative</td><td>Negative</td><td>Negative</td></tr><tr><td colspan="4">Biochemistry</td></tr><tr><td>&#xA0;&#xA0;Catalase</td><td>+</td><td>+</td><td>+</td></tr><tr><td>&#xA0;&#xA0;Oxidase</td><td>+</td><td>+</td><td>&#x2013;</td></tr><tr><td>&#xA0;&#xA0;O/F test</td><td>&#x2013;/&#x2013;</td><td>&#x2013;/&#x2013;</td><td>&#x2013;/&#x2013;</td></tr><tr><td>&#xA0;&#xA0;Motility</td><td>+</td><td>+</td><td>&#x2013;</td></tr><tr><td>&#xA0;&#xA0;Lysine/BBL Ox/Ferm Tube II</td><td>&#x2013;</td><td>+</td><td>n.d.</td></tr><tr><td>&#xA0;&#xA0;Result</td><td><italic>Achromobacter </italic>spp. or <italic>Pseudomonas </italic>spp.</td><td><italic>Achromobacter </italic>spp.</td><td><italic>Acinetobacter </italic>spp.</td></tr><tr><td colspan="4">Api 20 NE</td></tr><tr><td>&#xA0;&#xA0;NO<sub>3</sub>, nitrate reduction</td><td>+</td><td>+</td><td>&#x2013;</td></tr><tr><td>&#xA0;&#xA0;GLU, glucose</td><td>+</td><td>&#x2013;</td><td>&#x2013;</td></tr><tr><td>&#xA0;&#xA0;GNT, gluconate</td><td>+</td><td>+</td><td>&#x2013;</td></tr><tr><td>&#xA0;&#xA0;CAP, caprate</td><td>+</td><td>&#x2013;</td><td>+</td></tr><tr><td>&#xA0;&#xA0;ADI, adipate</td><td>+</td><td>+</td><td>&#x2013;</td></tr><tr><td>&#xA0;&#xA0;MLT, maltose</td><td>+</td><td>+</td><td>+</td></tr><tr><td>&#xA0;&#xA0;CIT, citrate</td><td>+</td><td>+</td><td>&#x2013;</td></tr><tr><td>&#xA0;&#xA0;PAC, phenylacetate</td><td>+</td><td>+</td><td>+</td></tr><tr><td>&#xA0;&#xA0;OX, oxidase</td><td>+</td><td>+</td><td>&#x2013;</td></tr><tr><td>&#xA0;&#xA0;Result</td><td><italic>A. xylosoxidans</italic> (94.5%)</td><td><italic>A. denitrificans</italic> (82.2%)</td><td><italic>A. lwoffii</italic> (98.1%)</td></tr><tr><td colspan="4">VITEK 2</td></tr><tr><td>&#xA0;&#xA0;N-LGGH, &#x3B3;-L-glutamyl (nutrient assimilation, NA)</td><td>+</td><td>+</td><td>n.d.</td></tr><tr><td>&#xA0;&#xA0;P-BPHO, bis(p-nitrophenyl)phosphate</td><td>+</td><td>&#x2013;</td><td>n.d.</td></tr><tr><td>&#xA0;&#xA0;C-CIT, citrate</td><td>&#x2013;</td><td>+</td><td>n.d.</td></tr><tr><td>&#xA0;&#xA0;C-KGA, &#x3B1;-acetoglutaryc acid</td><td>+</td><td>+</td><td>n.d.</td></tr><tr><td>&#xA0;&#xA0;N-LPROT, L-proline-NA</td><td>+</td><td>&#x2013;</td><td>n.d.</td></tr><tr><td>&#xA0;&#xA0;Result</td><td><italic>Achromobacter </italic>spp. (90%)</td><td><italic>Achromobacter </italic>spp. (90%)</td><td>n.d.</td></tr></tbody></table><table-wrap-foot><p><italic> n.d. </italic>not determined</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec14">
        <title>[<sup>3</sup>H]Adenine binding assays with isolated, intact bacteria</title>
        <p>Adenine competition binding studies were performed using isolated, intact bacteria (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>b). The IC<sub>50</sub> value obtained with whole bacterial cells of <italic>A. xylosoxidans</italic> (<inline-formula id="IEq11"><!-- Alternate image not processed: 11302_2007_9060_Article_IEq11.gif --><tex-math id="M11">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{IC}}_{{50}}  = 13.8 \pm 2.7\;{\text{nM}} $$\end{document}</tex-math></inline-formula>) was in the same concentration range as that obtained with membrane preparations of the same bacteria, previously designated contaminant 1 (<inline-formula id="IEq12"><!-- Alternate image not processed: 11302_2007_9060_Article_IEq12.gif --><tex-math id="M12">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{IC}}_{{50}}  = 4.59 \pm 0.49 $$\end{document}</tex-math></inline-formula>). For the other two bacteria, <italic>A. denitrificans</italic> and <italic>A. lwoffii</italic>, IC<sub>50</sub> values were 5- to 10-fold lower when determined in whole bacterial cells compared with membrane preparations. From the homologous competition experiments, K<sub>D</sub> and B<sub>max</sub> values were estimated for <italic>A. xylosoxidans</italic> (membranes and intact cells). For bacterial membrane preparations, a K<sub>D</sub> value of 5.84&#x2009;&#xB1;&#x2009;1.12&#xA0;nM and a B<sub>max</sub> value of 266&#x2009;&#xB1;&#x2009;65&#xA0;pmol/mg protein was calculated (<italic>n</italic>&#x2009;=&#x2009;3). For the intact bacteria, a K<sub>D</sub> value of 11.0&#x2009;&#xB1;&#x2009;1.2&#xA0;nM and a B<sub>max</sub> value of 780,000&#x2009;&#xB1;&#x2009;120,000 sites/cell (<italic>n</italic>&#x2009;=&#x2009;8) was obtained.</p>
      </sec>
      <sec id="Sec15">
        <title>Structure&#x2013;activity relationships</title>
        <p>Affinities for selected compounds at adenine binding sites of <italic>A. xylosoxidans</italic> were determined in competition assays using whole bacterial cells and compared with data obtained in binding studies at the rat brain adenine receptor [<xref ref-type="bibr" rid="CR7">7</xref>]. Figure&#xA0;<xref rid="Fig4" ref-type="fig">4</xref> shows competition curves for selected compounds, which exhibited high affinity, i.e., adenine (<inline-formula id="IEq13"><!-- Alternate image not processed: 11302_2007_9060_Article_IEq13.gif --><tex-math id="M13">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{IC}}_{{50}}  = 13.8 \pm 2.7\;{\text{nM}} $$\end{document}</tex-math></inline-formula>), hypoxanthine (<inline-formula id="IEq14"><!-- Alternate image not processed: 11302_2007_9060_Article_IEq14.gif --><tex-math id="M14">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{IC}}_{{50}}  = 59.1 \pm 19.6\;{\text{nM}} $$\end{document}</tex-math></inline-formula>), and 2-fluoroadenine (<inline-formula id="IEq15"><!-- Alternate image not processed: 11302_2007_9060_Article_IEq15.gif --><tex-math id="M15">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{IC}}_{{50}}  = 32,100 \pm 3000\;{\text{nM}} $$\end{document}</tex-math></inline-formula>). The results for all compounds tested are summarized in Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>. Whereas the affinity of adenine for the binding sites of <italic>A. xylosoxidans</italic> was in the same range as for the rat adenine receptor, the affinities for hypoxanthine and 2-fluoroadenine differed substantially from those determined for the rat adenine receptor. Hypoxanthine showed very low affinity for the rat adenine receptor (K<sub>i</sub> 45,000&#x2009;&#xB1;&#x2009;19,400&#xA0;nM), but high affinity for the bacterial [<sup>3</sup>H]adenine binding sites, with an IC<sub>50</sub> value in the low nanomolar range (59.1&#x2009;&#xB1;&#x2009;2.0&#xA0;nM). For 2-fluoroadenine, the opposite was true: the K<sub>i</sub> value for rat brain cortical adenine receptor was 620&#x2009;&#xB1;&#x2009;140&#xA0;nM [<xref ref-type="bibr" rid="CR7">7</xref>], whereas the IC<sub>50</sub> value for the <italic>A. xylosoxidans</italic> binding site was in the micromolar range (32,100&#x2009;&#xB1;&#x2009;3,000&#xA0;nM).
<fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>Competition curves for adenine, hypoxanthine and 2-fluoroadenine versus 10&#xA0;nM [<sup>3</sup>H]adenine obtained with <italic>Achromobacter xylosoxidans</italic> (intact bacteria) (<inline-formula id="IEq16"><!-- Alternate image not processed: 11302_2007_9060_Article_IEq16.gif --><tex-math id="M16">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$${\text{IC}}_{{50}} \,{\text{values}}:\,{\text{adenine}} = 13.8 \pm 2.7\;{\text{nM}}\;{\left( {n = 8} \right)}$$\end{document}</tex-math></inline-formula>; <inline-formula id="IEq17"><!-- Alternate image not processed: 11302_2007_9060_Article_IEq17.gif --><tex-math id="M17">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$${\text{hypoxanthine}} = 59.1 \pm 19.6\;{\text{nM}}\;{\left( {n = 3} \right)}$$\end{document}</tex-math></inline-formula>; <inline-formula id="IEq18"><!-- Alternate image not processed: 11302_2007_9060_Article_IEq18.gif --><tex-math id="M18">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$2 - {\text{fluoroadenine}} = 32,100 \pm 3000\;{\text{nM}}\;{\left( {n = 3} \right)}$$\end{document}</tex-math></inline-formula></p></caption><graphic position="anchor" xlink:href="11302_2007_9060_Fig4_HTML" id="MO4"/></fig><table-wrap id="Tab2"><label>Table&#xA0;2</label><caption><p>Comparison of affinities of adenine and selected compounds for the rat adenine receptor and bacterial binding sites determined in radioligand binding studies</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Compound</th><th><italic>Achromobacter xylosoxidans</italic> (intact bacteria)</th><th>Rat brain cortical membranes</th></tr><tr><th>IC<sub>50</sub> &#xB1; SEM [&#x3BC;M]<sup>a</sup> (% inhibition &#xB1; SEM at 10&#xA0;&#x3BC;M)</th><th>K<sub>i</sub> &#xB1; SEM [&#x3BC;M]<sup>a</sup> (% inhibition &#xB1; SEM at 100&#xA0;&#x3BC;M)</th></tr></thead><tbody><tr><td>Adenine</td><td>0.0138&#x2009;&#xB1;&#x2009;0.0027<sup>b</sup></td><td>0.0299&#x2009;&#xB1;&#x2009;0.0034<sup>c</sup></td></tr><tr><td>2-Fluoroadenine</td><td>32.1&#x2009;&#xB1;&#x2009;3.0</td><td>0.62&#x2009;&#xB1;&#x2009;0.14<sup>c</sup></td></tr><tr><td>2-Hydroxyadenine</td><td>&#x226B;10 (7&#x2009;&#xB1;&#x2009;15)<sup>d</sup></td><td>29.4&#x2009;&#xB1;&#x2009;6.4</td></tr><tr><td>2,6-Diaminopurine</td><td>&#x226B;10 (3&#x2009;&#xB1;&#x2009;8)<sup>d</sup></td><td>4.95&#x2009;&#xB1;&#x2009;0.75</td></tr><tr><td>1,N<sup>6</sup>-Ethenoadenine</td><td>ca. 10 (53&#x2009;&#xB1;&#x2009;6)<sup>d</sup></td><td>34.4&#x2009;&#xB1;&#x2009;8.1</td></tr><tr><td>Hypoxanthine</td><td>0.0591&#x2009;&#xB1;&#x2009;0.0196</td><td>45.0&#x2009;&#xB1;&#x2009;19.4</td></tr><tr><td>Uracil</td><td>&#x226B;10 (6&#x2009;&#xB1;&#x2009;1)</td><td>&#x226B;100 (&#x2212;6&#x2009;&#xB1;&#x2009;2)</td></tr><tr><td>Xanthine</td><td>&gt;10 (17&#x2009;&#xB1;&#x2009;6)</td><td>&gt;100 (23&#x2009;&#xB1;&#x2009;7)</td></tr><tr><td>Uridine</td><td>&#x226B;10 (5 &#xB1; 5)<sup>d</sup></td><td>&#x226B;100 (&#x2212;9 &#xB1; 3)</td></tr><tr><td>Adenosine</td><td>&#x226B;10 (12 &#xB1; 9)<sup>d</sup></td><td>19.4&#x2009;&#xB1;&#x2009;6.3<sup>c</sup></td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Results are from three independent experiments performed in triplicate, unless otherwise noted</p><p><sup>b</sup>Results are from eight independent experiments performed in triplicate</p><p><sup>c</sup>K<sub>i</sub> values and % inhibition values are from [<xref ref-type="bibr" rid="CR7">7</xref>]</p><p><sup>d</sup>Results from two independent experiments performed in triplicate</p></table-wrap-foot></table-wrap></p>
      </sec>
    </sec>
    <sec id="Sec16" sec-type="discussion">
      <title>Discussion</title>
      <p>[<sup>3</sup>H]Adenine has been successfully used by us [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>] and other laboratories [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR10">10</xref>] to label the recently discovered rat and mouse adenine receptors. However, problems with [<sup>3</sup>H]adenine binding assays have been reported by two laboratories [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. These have led to the suggestion that [<sup>3</sup>H]adenine was not a suitable radioligand for the labeling of G protein-coupled adenine receptors [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. IJzerman and coworkers [<xref ref-type="bibr" rid="CR12">12</xref>] reported that [<sup>3</sup>H]adenine binding was not protein dependent and that it bound with nanomolar affinity to glass fiber filters in the absence of added protein. These results, which were contradictory to our own data, prompted us to reexamine the [<sup>3</sup>H]adenine binding results that we had obtained during the past years, trying to find an explanation for the discrepancies.</p>
      <p>In contrast to the results reported by IJzerman and coworkers [<xref ref-type="bibr" rid="CR12">12</xref>], binding of [<sup>3</sup>H]adenine to various membrane preparations was strictly protein dependent in our hands, as expected (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). Specific binding linearly increased with increased amounts of protein and thus increased numbers of adenine receptors. Nonspecific binding was generally low for [<sup>3</sup>H]adenine, and there was only a minor increase in nonspecific binding with increasing protein concentrations. In the absence of protein, no specific binding was observed (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>b). These results indicated that [<sup>3</sup>H]adenine was a suitable radioligand for labeling adenine receptors. In fact, we could recently perform [<sup>3</sup>H]adenine binding assays on a null background for the first time, namely, at the mouse adenine receptor heterologously expressed in Sf21 insect cells. Whereas membrane preparations of the nontransfected Sf21 cells did not exhibit any specific [<sup>3</sup>H]adenine binding, cell membranes prepared from cells infected with recombinant baculoviruses bound [<sup>3</sup>H]adenine with high affinity [<xref ref-type="bibr" rid="CR6">6</xref>].</p>
      <p>However, when we looked carefully at all of our previous [<sup>3</sup>H]adenine binding data, we found a few [<sup>3</sup>H]adenine binding experiments that could not be evaluated due to unusually high radioactivity counts. These occasional problems had been solved by carefully controlling the experimental conditions, e.g., by using freshly prepared buffer solutions. Stimulated by the experiences reported by the IJzerman group [<xref ref-type="bibr" rid="CR12">12</xref>], we decided to perform a systematic study to find out the reasons for those problems, which might also be causative for erroneous [<sup>3</sup>H]adenine binding results in other laboratories [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>].</p>
      <p>High affinity binding of [<sup>3</sup>H]adenine to filter paper, as suggested by IJzerman and coworkers [<xref ref-type="bibr" rid="CR12">12</xref>], could be excluded by our experiments, as buffer solutions that were freshly prepared did not show any specific [<sup>3</sup>H]adenine binding in filtration assays using glass fiber GF/B filters, the same filters that had been used by the IJzerman group [<xref ref-type="bibr" rid="CR12">12</xref>]. On the contrary, we discovered that bacterial contaminations, which can be present in buffer solutions, express high-affinity binding sites for [<sup>3</sup>H]adenine and therefore impede adenine receptor binding assays. When we examined different buffer solutions stored in our laboratory, we discovered high [<sup>3</sup>H]adenine binding in Tris-HCl buffer solution (pH 7.4) stored at 4&#xB0;C in a 5-l plastic container. That container had only a small orifice and was therefore difficult to purify. Thus, microbial contamination in this container was carried over when new buffer solution was prepared. When the contaminated buffer was filtered through a bacteria-tight filter (0.2&#xA0;&#x3BC;m) or heated in order to denature proteins, specific [<sup>3</sup>H]adenine binding was abolished, strongly indicating that microbial proteins were responsible for the high affinity binding of adenine. A further indication that a living organism was involved was the fact that adenine binding increased exponentially with time. Interestingly, the microorganisms grew better at 4&#xB0;C than at room temperature.</p>
      <p>Our first presumption, that the contaminants might belong to yeast, could not be proven. <italic>Saccharomyces cerevisiae</italic> was used as a control organism for binding studies but showed no [<sup>3</sup>H]adenine binding (data not shown). Three microorganisms were isolated from the contaminated Tris-buffer solution and identified using standard procedures and kits. Two of these contaminants were assigned to the genera <italic>Achromobacter</italic> and one to <italic>Acinetobacter</italic>. Both bacteria species are gram-negative rods and are strictly aerobic. They are commonly found in soil and water [<xref ref-type="bibr" rid="CR17">17</xref>]. For healthy humans or animals, they are not pathogenic, but especially <italic>A. xylosoxidans</italic> and <italic>A. lwoffii</italic> have gained increasing importance due to their ability to cause nosocomial infections [<xref ref-type="bibr" rid="CR22">22</xref>&#x2013;<xref ref-type="bibr" rid="CR32">32</xref>]. These bacteria are able to grow under nonoptimal conditions, such as low temperature and restricted nutrient supply [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR24">24</xref>&#x2013;<xref ref-type="bibr" rid="CR26">26</xref>]. They are able to metabolize a wide variety of organic substances, such as chemical pollutants in the environment, and can therefore be used as bioreporters and for the degradation of pollutants [<xref ref-type="bibr" rid="CR33">33</xref>&#x2013;<xref ref-type="bibr" rid="CR36">36</xref>]. This is consistent with the fact that these bacteria are able to grow in simple Tris-HCl buffer at low temperature.</p>
      <p>Both <italic>A. lwoffii</italic> and <italic>Achromobacter </italic>spp., exhibit specific binding sites for adenine, with IC<sub>50</sub> values as low as 13&#xA0;nM for <italic>A. xylosoxidans</italic>. Thus, the detected adenine binding site in <italic>A. xylosoxidans</italic> exhibits an even higher affinity than the rat (29.9&#xA0;nM [<xref ref-type="bibr" rid="CR7">7</xref>], 18&#xA0;nM [<xref ref-type="bibr" rid="CR5">5</xref>]) or mouse (54.9&#xA0;nM [<xref ref-type="bibr" rid="CR6">6</xref>]) adenine receptor. The binding affinities for <italic>A. lwoffii</italic> and <italic>A. denitrificans</italic> were more that 70-fold lower, with affinities in the low micromolar range (1&#xA0;&#x3BC;M and 2.4&#xA0;&#x3BC;M, respectively) when membrane preparations were analyzed and about 20-fold lower when intact cells were investigated for binding (299&#xA0;nM and 253&#xA0;nM, respectively). For <italic>A. xylosoxidans</italic>, only a threefold difference was found when binding affinities for membranes were compared with those with intact cells (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). The specific, high-affinity [<sup>3</sup>H]adenine binding site in <italic>A. xylosoxidans</italic> appeared to be expressed in extraordinarily high density, as amounts of membrane preparations that contained more than 1&#xA0;&#x3BC;g of protein/assay tube led to depletion of the radioligand (i.e., more than 50% of the added radioligand was bound to the protein). Rough estimations of receptor densities by homologous competition assays confirmed the high expression levels.</p>
      <p>So far, the nature of these high-affinity adenine binding sites in bacteria is not known. However, bacteria express a large number of transporters, including nucleobase transporters, in order to secure their nutrient supply (for review see [<xref ref-type="bibr" rid="CR37">37</xref>]). Nucleobase transport in bacteria has been mainly studied in <italic>Escherichia coli</italic> and <italic>Bacillus</italic> spp., as well as in the fungi <italic>Aspergillus nidulans</italic> and <italic>Neurospora crassa</italic> [<xref ref-type="bibr" rid="CR37">37</xref>&#x2013;<xref ref-type="bibr" rid="CR39">39</xref>]. Usually, these transporters fulfill two main functions. Firstly, purines can serve as preformed bases for nucleotide biosynthesis, and secondly, they serve as nitrogen sources [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. Distinct adenine uptake systems have been identified, e.g., in <italic>E. coli</italic> [<xref ref-type="bibr" rid="CR42">42</xref>]. The high density of the detected [<sup>3</sup>H]adenine binding sites in <italic>A. xylosoxidans</italic> would be consistent with its function as a purine transporter and points to an important role of this protein, which appears to be upregulated when the bacteria are transferred to Tris buffer (unpublished observation), a medium poor in nutrients. Such an effect has been described for protozoa [<xref ref-type="bibr" rid="CR43">43</xref>]: purine salvage enzymes and transporters can be dramatically up- or down-regulated according to growth stage and availability of purine sources [<xref ref-type="bibr" rid="CR44">44</xref>]. Examples are the high-affinity hypoxanthine transporter in <italic>Trypanosoma brucei brucei</italic>, which shows a 450% increased transport rate after 24&#xA0;h of purine deprivation, and the adenine transporter in <italic>Crithidia luciliae</italic>, which shows a &gt;100-fold increase of adenine uptake after purine starvation [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>].</p>
      <p>For <italic>E. coli</italic> as well as for <italic>B. subtilis</italic>, two adenine transport systems have been described: a low- and a high-affinity transport system [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. The latter system is important when the concentration of adenine is low [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. Differences in adenine-binding affinity observed in our studies when intact cells were compared with membrane preparations (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>) might be explained by the existence of different transporters in the bacteria (<italic>Achromobacter</italic> and <italic>Acinetobacter</italic>). Whereas bacterial membrane preparations were obtained directly from an overnight culture grown in complete medium, binding studies at whole bacteria were performed after growing them in Tris-HCl buffer, a nutrient-poor medium, in which they may have upregulated the high-affinity transporters [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR47">47</xref>].</p>
      <p>In order to investigate the structure&#x2013;activity relationships of the high-affinity adenine binding site in <italic>A. xylosoxidans</italic>, a series of compounds, including adenine derivatives, other purines, and pyrimidines (uracil, xanthine, hypoxanthine), and nucleosides (uridine, adenosine) were investigated in binding studies, and the results were compared with those obtained at the rat adenine receptor. As expected, structure&#x2013;activity relationships at the rat adenine receptor were very different from those at the bacterial adenine binding site. Hypoxanthine, for example, which exhibits a low affinity for the rat adenine receptor (45,000&#xA0;nM), bound to the bacterial site with 760-fold higher affinity (59.1&#xA0;nM), and 2-fluoroadenine, which showed a high affinity for murine adenine receptors (620&#xA0;nM), bound with a 50-fold lower affinity (32,100&#xA0;nM) to the bacterial site. Several compounds that had shown affinity in the micromolar range at rat adenine receptors (adenosine, 2-hydroxyadenine, 2,6-diaminopurine) were completely inactive at <italic>Achromobacter</italic> binding sites.</p>
      <p>Alexander had previously reported that hypoxanthine at a concentration of 10&#xA0;&#x3BC;M completely blocked [<sup>3</sup>H]adenine binding to rat brain membranes in his experiments, the results of which were not consistent with the labeling of a G protein-coupled adenine receptor [<xref ref-type="bibr" rid="CR11">11</xref>]. It might be speculated that he actually labeled a bacterial adenine binding site rather than the rat adenine receptor, which would explain the discrepant results. The limited number of compounds (five) investigated by IJzerman and coworkers [<xref ref-type="bibr" rid="CR12">12</xref>] do not allow a full comparison of the structure&#x2013;activity relationships, but large differences were observed for two compounds&#x2014;5&#x2032;-deoxyadenosine (725,000&#xA0;nM [<xref ref-type="bibr" rid="CR12">12</xref>] vs. 823&#xA0;nM (rat adenine receptor) [<xref ref-type="bibr" rid="CR10">10</xref>]) and 2-fluoroadenine (19,000&#xA0;nM [<xref ref-type="bibr" rid="CR12">12</xref>], 620&#xA0;nM (rat adenine receptor) [<xref ref-type="bibr" rid="CR7">7</xref>])&#x2014;indicating the labeling of a very different, presumably a bacterial, binding site by the authors [<xref ref-type="bibr" rid="CR12">12</xref>]. The fact that hypoxanthine exhibits high affinity for the [<sup>3</sup>H]adenine binding site in <italic>A. xylosoxidans</italic> in the same concentration range as adenine itself is another indication that the labeled protein may be a purine transporter.</p>
      <p>Nucleobase transporters have been identified in bacteria, fungi, protozoa, algae, plants, and mammals, but only few have been cloned and analyzed in detail [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. Five basic families of nucleobase transporters have been described: the nucleobase-ascorbate transporters (NAT), which include members from archaea, eubacteria, fungi, plants, and metazoa; the purine-related transporters (PRP), which are restricted to procaryotes and fungi; the purine permeases (PUP), which are purine transporters exclusively found in plants; and the equilibrative (ENT) and concentrative (CNT) nucleoside transporters, which not only transport nucleosides but may also transport nucleobases [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR48">48</xref>&#x2013;<xref ref-type="bibr" rid="CR52">52</xref>]. Bacteria have developed different transport systems for related compounds, which allow them to independently absorb those compounds. This is an advantage when growing under nutritional deprivation [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. For <italic>C. luciliae</italic>, a nucleobase transporter that recognizes adenine and hypoxanthine equally well has been described [<xref ref-type="bibr" rid="CR45">45</xref>]. In <italic>E. coli</italic>, adenine and uracil have different, specific transport systems, as do xanthine and guanine, whereas hypoxanthine might utilize the guanine transporter [<xref ref-type="bibr" rid="CR53">53</xref>]. For <italic>B. subtilis</italic>, specific transport systems for guanine and hypoxanthine, for guanosine and inosine, as well as three independent uptake systems for adenine, adenosine and uracil, have been identified [<xref ref-type="bibr" rid="CR46">46</xref>].</p>
      <p>From the described observations, we conclude that the high-affinity binding sites found in bacteria isolated from Tris-buffer solutions have not much in common with the adenine receptors found in mammals. The genomes of the bacteria <italic>A. baumannii</italic> and of several closely related bacteria, such as <italic>Pseudomonas </italic>spp. are known. Therefore, we performed a search to identify potential sequences with homology to the rat and mouse adenine receptors, which, however, yielded no hits. It appears likely that [<sup>3</sup>H]adenine labels a high-affinity nucleobase transporter for adenine and hypoxanthine in <italic>Achromobacter </italic>spp., a bacterium isolated as a contaminant from Tris-HCl buffer. The high affinity in the low nanomolar range is in fact unusual; therefore, it may be speculated that the labeled protein might belong to a new type of high-affinity bacterial nucleobase transporter.</p>
    </sec>
    <sec id="Sec17" sec-type="conclusion">
      <title>Conclusions</title>
      <p>In conclusion, we have demonstrated that [<sup>3</sup>H]adenine is a well-suited radioligand for the labeling of G protein-coupled adenine receptors, but precaution is advised for preparing and storing buffers used for the assays to avoid bacterial contaminations. After systematically analyzing occasionally encountered irregularities in [<sup>3</sup>H]adenine binding assays, we were able to isolate three bacteria, commonly found in soil and water, from Tris-HCl buffer. They were identified as <italic>A. lwoffii</italic>, <italic>A. xylosoxidans,</italic> and <italic>A. denitrificans</italic> and revealed high-affinity binding sites for [<sup>3</sup>H]adenine.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>This work was supported by the Deutsche Forschungsgemeinschaft (GRK 677). Thanks are due to Hannah Ulm, undergraduate student of molecular biomedicine, for performing some of the binding experiments, and Sylvia Hack, from the Hygiene Institute of the University of Bonn, for running identification procedures (Api 20 NE and VITEK systems).</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Physiology and pathophysiology of purinergic neurotransmission</article-title>
          <source>Physiol Rev</source>
          <year>2007</year>
          <volume>87</volume>
          <fpage>659</fpage>
          <lpage>797</lpage>
          <pub-id pub-id-type="doi">10.1152/physrev.00043.2006</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87:659&#x2013;797 <pub-id pub-id-type="pmid">17429044</pub-id></citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fredholm</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>IJzerman</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Klotz</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Linden</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>International Union of Pharmacology XXV. Nomenclature and classification of adenosine receptors</article-title>
          <source>Pharmacol Rev</source>
          <year>2001</year>
          <volume>53</volume>
          <fpage>527</fpage>
          <lpage>552</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527&#x2013;552 <pub-id pub-id-type="pmid">11734617</pub-id></citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>K&#xFC;gelgen</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Wetter</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Molecular pharmacology of P2Y-receptors</article-title>
          <source>Naunyn Schmiedeberg&#x2019;s Arch Pharmacol</source>
          <year>2000</year>
          <volume>362</volume>
          <fpage>310</fpage>
          <lpage>323</lpage>
          <pub-id pub-id-type="doi">10.1007/s002100000310</pub-id>
        </citation>
        <citation citation-type="display-unstructured">von K&#xFC;gelgen I, Wetter A (2000) Molecular pharmacology of P2Y-receptors. Naunyn Schmiedeberg&#x2019;s Arch Pharmacol 362:310&#x2013;323 </citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khakh</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>North</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>P2X receptors as cell-surface ATP sensors in health and disease</article-title>
          <source>Nature</source>
          <year>2006</year>
          <volume>442</volume>
          <fpage>527</fpage>
          <lpage>532</lpage>
          <pub-id pub-id-type="doi">10.1038/nature04886</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Khakh BS, North RA (2006) P2X receptors as cell-surface ATP sensors in health and disease. Nature 442:527&#x2013;532 <pub-id pub-id-type="pmid">16885977</pub-id></citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bender</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Buist</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jurzak</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Langlois</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Baggerman</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Verhasselt</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ercken</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>HQ</given-names>
            </name>
            <name>
              <surname>Wintmolders</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wyngaert</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Oers</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Schoofs</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Luyten</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Characterization of an orphan G protein-coupled receptor localized in the dorsal root ganglia reveals adenine as a signaling molecule</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>8573</fpage>
          <lpage>8578</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.122016499</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Bender E, Buist A, Jurzak M, Langlois X, Baggerman G, Verhasselt P, Ercken M, Guo HQ, Wintmolders C, Van den Wyngaert I, Van Oers I, Schoofs L, Luyten W (2002) Characterization of an orphan G protein-coupled receptor localized in the dorsal root ganglia reveals adenine as a signaling molecule. Proc Natl Acad Sci USA 99:8573&#x2013;8578 <pub-id pub-id-type="pmid">12084918</pub-id></citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <citation citation-type="other">von K&#xFC;gelgen I, Schiedel AC, Hoffmann K, Alsdorf BBA, Abdelrahman A, M&#xFC;ller CE (2007) Cloning and functional expression of a novel G<sub>i</sub> protein-coupled receptor for adenine from mouse brain, submitted</citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gorzalka</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Vittori</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Volpini</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cristalli</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>K&#xFC;gelgen</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <article-title>Evidence for the functional expression and pharmacological characterization of adenine receptors in native cells and tissues</article-title>
          <source>Mol Pharmacol</source>
          <year>2005</year>
          <volume>67</volume>
          <fpage>955</fpage>
          <lpage>964</lpage>
          <pub-id pub-id-type="doi">10.1124/mol.104.006601</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Gorzalka S, Vittori S, Volpini R, Cristalli G, von K&#xFC;gelgen I, M&#xFC;ller CE (2005) Evidence for the functional expression and pharmacological characterization of adenine receptors in native cells and tissues. Mol Pharmacol 67:955&#x2013;964 <pub-id pub-id-type="pmid">15604413</pub-id></citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brunschweiger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <article-title>P2 receptors activated by uracil nucleotides&#x2014;an update</article-title>
          <source>Curr Med Chem</source>
          <year>2006</year>
          <volume>13</volume>
          <fpage>289</fpage>
          <lpage>312</lpage>
          <pub-id pub-id-type="doi">10.2174/092986706775476052</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Brunschweiger A, M&#xFC;ller CE (2006) P2 receptors activated by uracil nucleotides&#x2014;an update. Curr Med Chem 13:289&#x2013;312 <pub-id pub-id-type="pmid">16475938</pub-id></citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bylund</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Toews</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Radioligand binding methods: practical guide and tips</article-title>
          <source>Am J Physiol</source>
          <year>1993</year>
          <volume>265</volume>
          <fpage>L421</fpage>
          <lpage>L429</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bylund DB, Toews ML (1993) Radioligand binding methods: practical guide and tips. Am J Physiol 265:L421&#x2013;L429 <pub-id pub-id-type="pmid">8238529</pub-id></citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Watanabe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ikekita</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakata</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Identification of specific [<sup>3</sup>H]adenine-binding sites in rat brain membranes</article-title>
          <source>J Biochem (Tokyo)</source>
          <year>2005</year>
          <volume>137</volume>
          <fpage>323</fpage>
          <lpage>329</lpage>
        </citation>
        <citation citation-type="display-unstructured">Watanabe S, Ikekita M, Nakata H (2005) Identification of specific [3H]adenine-binding sites in rat brain membranes. J Biochem (Tokyo) 137:323&#x2013;329 <pub-id pub-id-type="pmid">15809333</pub-id></citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <citation citation-type="other">Alexander SPH (2004) Binding of [<sup>3</sup>H]adenine to rat brain membranes. Proc Brit Pharmacol Soc <ext-link ext-link-type="uri" xlink:href="http://www.pa2online.org/Vol2Issue4abst120P.html">http://www.pa2online.org/Vol2Issue4abst120P.html</ext-link></citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <citation citation-type="other">Ye K, Mulder-Krieger T, Beukers MW, IJzerman AP (2006) [<sup>3</sup>H]Adenine&#x2019;s high filter binding precludes its use as a radioligand for the adenine receptor. Purinergic Signaling 2:71&#x2013;72</citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Griessmeier</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <article-title>[<sup>3</sup>H]BQ-123 binding to native endothelin ET<sub>A</sub> receptors in human astrocytoma 1321N1 cells and screening of potential ligands</article-title>
          <source>Pharmacology</source>
          <year>2005</year>
          <volume>74</volume>
          <fpage>51</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="doi">10.1159/000083983</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Griessmeier KJ, M&#xFC;ller CE (2005) [3H]BQ-123 binding to native endothelin ETA receptors in human astrocytoma 1321N1 cells and screening of potential ligands. Pharmacology 74:51&#x2013;56 <pub-id pub-id-type="pmid">15714006</pub-id></citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klotz</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Hessling</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hegler</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Owman</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kull</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fredholm</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Lohse</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells</article-title>
          <source>Naunyn Schmiedeberg&#x2019;s Arch Pharmacol</source>
          <year>1998</year>
          <volume>357</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1007/PL00005131</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, Lohse MJ (1998) Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmiedeberg&#x2019;s Arch Pharmacol 357:1&#x2013;9 </citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lowry</surname>
              <given-names>OH</given-names>
            </name>
            <name>
              <surname>Rosebrough</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Farr</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Randall</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Protein measurement with the folin phenol reagent</article-title>
          <source>J Biol Chem</source>
          <year>1951</year>
          <volume>193</volume>
          <fpage>265</fpage>
          <lpage>275</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265&#x2013;275 <pub-id pub-id-type="pmid">14907713</pub-id></citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bergonzelli</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Donnicola</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Porta</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Corthesy-Theulaz</surname>
              <given-names>IE</given-names>
            </name>
          </person-group>
          <article-title>Essential oils as components of a diet-based approach to management of <italic>Helicobacter</italic> infection</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2003</year>
          <volume>47</volume>
          <fpage>3240</fpage>
          <lpage>3246</lpage>
          <pub-id pub-id-type="doi">10.1128/AAC.47.10.3240-3246.2003</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Bergonzelli GE, Donnicola D, Porta N, Corthesy-Theulaz IE (2003) Essential oils as components of a diet-based approach to management of Helicobacter infection. Antimicrob Agents Chemother 47:3240&#x2013;3246 <pub-id pub-id-type="pmid">14506036</pub-id></citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Garrity</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <source>Bergey&#x2019;s manual of systematic bacteriology</source>
          <year>1984</year>
          <publisher-loc>Baltimore</publisher-loc>
          <publisher-name>Williams and Wilkins</publisher-name>
        </citation>
        <citation citation-type="display-unstructured">Garrity GM (1984) Bergey&#x2019;s manual of systematic bacteriology. Williams and Wilkins, Baltimore </citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klotz</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Lohse</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Schwabe</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Cristalli</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vittori</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Grifantini</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>2-Chloro-N<sup>6</sup>-[<sup>3</sup>H]cyclopentyladenosine ([<sup>3</sup>H]CCPA) - a high affinity agonist radioligand for A<sub>1</sub> adenosine receptors</article-title>
          <source>Naunyn Schmiedeberg&#x2019;s Arch Pharmacol</source>
          <year>1989</year>
          <volume>340</volume>
          <fpage>679</fpage>
          <lpage>683</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00717744</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Klotz KN, Lohse MJ, Schwabe U, Cristalli G, Vittori S, Grifantini M (1989) 2-Chloro-N6-[3H]cyclopentyladenosine ([3H]CCPA) - a high affinity agonist radioligand for A1 adenosine receptors. Naunyn Schmiedeberg&#x2019;s Arch Pharmacol 340:679&#x2013;683 </citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Maurinsh</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sauer</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Binding of [<sup>3</sup>H]MSX-2 (3-(3-hydroxypropyl)-7-methyl-8-(<italic>m</italic>-methoxystyryl)-1-propargylxanthine) to rat striatal membranes - a new selective antagonist radioligand for A<sub>2A</sub> adenosine receptors</article-title>
          <source>Eur J Pharm Sci</source>
          <year>2000</year>
          <volume>10</volume>
          <fpage>259</fpage>
          <lpage>265</lpage>
          <pub-id pub-id-type="doi">10.1016/S0928-0987(00)00064-6</pub-id>
        </citation>
        <citation citation-type="display-unstructured">M&#xFC;ller CE, Maurinsh J, Sauer R (2000) Binding of [3H]MSX-2 (3-(3-hydroxypropyl)-7-methyl-8-(m-methoxystyryl)-1-propargylxanthine) to rat striatal membranes - a new selective antagonist radioligand for A2A adenosine receptors. Eur J Pharm Sci 10:259&#x2013;265 <pub-id pub-id-type="pmid">10838015</pub-id></citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Diekmann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Thorand</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ozola</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>[<sup>3</sup>H]8-Ethyl-4-methyl-2-phenyl-(8<italic>R</italic>)-4,5,7,8-tetrahydro-1<italic>H</italic>-imidazo[2,1-<italic>i</italic>]-purin-5-one ([<sup>3</sup>H]PSB-11) a novel high-affinity antagonist radioligand for human A<sub>3</sub> adenosine receptors</article-title>
          <source>Bioorg Med Chem Lett</source>
          <year>2002</year>
          <volume>12</volume>
          <fpage>501</fpage>
          <lpage>503</lpage>
          <pub-id pub-id-type="doi">10.1016/S0960-894X(01)00785-5</pub-id>
        </citation>
        <citation citation-type="display-unstructured">M&#xFC;ller CE, Diekmann M, Thorand M, Ozola V (2002) [3H]8-Ethyl-4-methyl-2-phenyl-(8R)-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]-purin-5-one ([3H]PSB-11) a novel high-affinity antagonist radioligand for human A3 adenosine receptors. Bioorg Med Chem Lett 12:501&#x2013;503 <pub-id pub-id-type="pmid">11814828</pub-id></citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>El-Tayeb</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Griessmeier</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and preliminary evaluation of [<sup>3</sup>H]PSB-0413 a selective antagonist radioligand for platelet P2Y<sub>12</sub> receptors</article-title>
          <source>Bioorg Med Chem Lett</source>
          <year>2005</year>
          <volume>15</volume>
          <fpage>5450</fpage>
          <lpage>5452</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2005.08.104</pub-id>
        </citation>
        <citation citation-type="display-unstructured">El-Tayeb A, Griessmeier KJ, M&#xFC;ller CE (2005) Synthesis and preliminary evaluation of [3H]PSB-0413 a selective antagonist radioligand for platelet P2Y12 receptors. Bioorg Med Chem Lett 15:5450&#x2013;5452 <pub-id pub-id-type="pmid">16213725</pub-id></citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spear</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Fuhrer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kirby</surname>
              <given-names>BD</given-names>
            </name>
          </person-group>
          <article-title><italic>Achromobacter xylosoxidans (Alcaligenes xylosoxidans subsp. xylosoxidans)</italic> bacteremia associated with a well-water source: case report and review of the literature</article-title>
          <source>J Clin Microbiol</source>
          <year>1988</year>
          <volume>26</volume>
          <fpage>598</fpage>
          <lpage>599</lpage>
        </citation>
        <citation citation-type="display-unstructured">Spear JB, Fuhrer J, Kirby BD (1988) Achromobacter xylosoxidans (Alcaligenes xylosoxidans subsp. xylosoxidans) bacteremia associated with a well-water source: case report and review of the literature. J Clin Microbiol 26:598&#x2013;599 <pub-id pub-id-type="pmid">3281982</pub-id></citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weitkamp</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>YW</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Midha</surname>
              <given-names>NK</given-names>
            </name>
            <name>
              <surname>Crowe</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Recurrent <italic>Achromobacter xylosoxidans</italic> bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome</article-title>
          <source>Clin Infect Dis</source>
          <year>2000</year>
          <volume>31</volume>
          <fpage>1183</fpage>
          <lpage>1187</lpage>
          <pub-id pub-id-type="doi">10.1086/317461</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Weitkamp JH, Tang YW, Haas DW, Midha NK, Crowe JE Jr (2000) Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome. Clin Infect Dis 31:1183&#x2013;1187 <pub-id pub-id-type="pmid">11073750</pub-id></citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Granowitz</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Keenholtz</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>A pseudoepidemic of <italic>Alcaligenes xylosoxidans</italic> attributable to contaminated saline</article-title>
          <source>Am J Infect Control</source>
          <year>1998</year>
          <volume>26</volume>
          <fpage>146</fpage>
          <lpage>148</lpage>
          <pub-id pub-id-type="doi">10.1016/S0196-6553(98)80035-7</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Granowitz EV, Keenholtz SL (1998) A pseudoepidemic of Alcaligenes xylosoxidans attributable to contaminated saline. Am J Infect Control 26:146&#x2013;148 <pub-id pub-id-type="pmid">9584810</pub-id></citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reverdy</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Freney</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fleurette</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Coulet</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Surgot</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marmet</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ploton</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Nosocomial colonization and infection by <italic>Achromobacter xylosoxidans</italic></article-title>
          <source>J Clin Microbiol</source>
          <year>1984</year>
          <volume>19</volume>
          <fpage>140</fpage>
          <lpage>143</lpage>
        </citation>
        <citation citation-type="display-unstructured">Reverdy ME, Freney J, Fleurette J, Coulet M, Surgot M, Marmet D, Ploton C (1984) Nosocomial colonization and infection by Achromobacter xylosoxidans. J Clin Microbiol 19:140&#x2013;143 <pub-id pub-id-type="pmid">6699141</pub-id></citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shigeta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yasunaga</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Honzumi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Okamura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kumata</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Endo</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Cerebral ventriculitis associated with <italic>Achromobacter xylosoxidans</italic></article-title>
          <source>J Clin Pathol</source>
          <year>1978</year>
          <volume>31</volume>
          <fpage>156</fpage>
          <lpage>161</lpage>
          <pub-id pub-id-type="doi">10.1136/jcp.31.2.156</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Shigeta S, Yasunaga Y, Honzumi K, Okamura H, Kumata R, Endo S (1978) Cerebral ventriculitis associated with Achromobacter xylosoxidans. J Clin Pathol 31:156&#x2013;161 <pub-id pub-id-type="pmid">632360</pub-id></citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Powell</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Meikle</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Microbial contamination of non-disposable instruments in otolaryngology out-patients</article-title>
          <source>J Laryngol Otol</source>
          <year>2003</year>
          <volume>117</volume>
          <fpage>122</fpage>
          <lpage>125</lpage>
          <pub-id pub-id-type="doi">10.1258/002221503762624567</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Powell S, Perry J, Meikle D (2003) Microbial contamination of non-disposable instruments in otolaryngology out-patients. J Laryngol Otol 117:122&#x2013;125 <pub-id pub-id-type="pmid">12625885</pub-id></citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patil</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Chopade</surname>
              <given-names>BA</given-names>
            </name>
          </person-group>
          <article-title>Distribution and <italic>in vitro</italic> antimicrobial susceptibility of <italic>Acinetobacter</italic> species on the skin of healthy humans</article-title>
          <source>Natl Med J India</source>
          <year>2001</year>
          <volume>14</volume>
          <fpage>204</fpage>
          <lpage>208</lpage>
        </citation>
        <citation citation-type="display-unstructured">Patil JR, Chopade BA (2001) Distribution and in vitro antimicrobial susceptibility of Acinetobacter species on the skin of healthy humans. Natl Med J India 14:204&#x2013;208 <pub-id pub-id-type="pmid">11547525</pub-id></citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gennari</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lombardi</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Comparative characterization of <italic>Acinetobacter</italic> strains isolated from different foods and clinical sources</article-title>
          <source>Zentralbl Bakteriol</source>
          <year>1993</year>
          <volume>279</volume>
          <fpage>553</fpage>
          <lpage>564</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gennari M, Lombardi P (1993) Comparative characterization of Acinetobacter strains isolated from different foods and clinical sources. Zentralbl Bakteriol 279:553&#x2013;564 <pub-id pub-id-type="pmid">8305813</pub-id></citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seifert</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Baginski</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Schulze</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pulverer</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>The distribution of <italic>Acinetobacter</italic> species in clinical culture materials</article-title>
          <source>Zentralbl Bakteriol</source>
          <year>1993</year>
          <volume>279</volume>
          <fpage>544</fpage>
          <lpage>552</lpage>
        </citation>
        <citation citation-type="display-unstructured">Seifert H, Baginski R, Schulze A, Pulverer G (1993) The distribution of Acinetobacter species in clinical culture materials. Zentralbl Bakteriol 279:544&#x2013;552 <pub-id pub-id-type="pmid">8305812</pub-id></citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Musa</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Desai</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Casewell</surname>
              <given-names>MW</given-names>
            </name>
          </person-group>
          <article-title>The survival of <italic>Acinetobacter calcoaceticus</italic> inoculated on fingertips and on formica</article-title>
          <source>J Hosp Infect</source>
          <year>1990</year>
          <volume>15</volume>
          <fpage>219</fpage>
          <lpage>227</lpage>
          <pub-id pub-id-type="doi">10.1016/0195-6701(90)90029-N</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Musa EK, Desai N, Casewell MW (1990) The survival of Acinetobacter calcoaceticus inoculated on fingertips and on formica. J Hosp Infect 15:219&#x2013;227 <pub-id pub-id-type="pmid">1971628</pub-id></citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bouvet</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Grimont</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>Identification and biotyping of clinical isolates of <italic>Acinetobacter</italic></article-title>
          <source>Ann Inst Pasteur Microbiol</source>
          <year>1987</year>
          <volume>138</volume>
          <fpage>569</fpage>
          <lpage>578</lpage>
          <pub-id pub-id-type="doi">10.1016/0769-2609(87)90042-1</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Bouvet PJ, Grimont PA (1987) Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur Microbiol 138:569&#x2013;578 <pub-id pub-id-type="pmid">3440090</pub-id></citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abd-El-Haleem</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Zaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Abulhamd</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Elbery</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Abu-Elreesh</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title><italic>Acinetobacter</italic> bioreporter assessing heavy metals toxicity</article-title>
          <source>J Basic Microbiol</source>
          <year>2006</year>
          <volume>46</volume>
          <fpage>339</fpage>
          <lpage>347</lpage>
          <pub-id pub-id-type="doi">10.1002/jobm.200510122</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Abd-El-Haleem D, Zaki S, Abulhamd A, Elbery H, Abu-Elreesh G (2006) Acinetobacter bioreporter assessing heavy metals toxicity. J Basic Microbiol 46:339&#x2013;347 <pub-id pub-id-type="pmid">17009289</pub-id></citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krauter</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Daily</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dibley</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Pinkart</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Legler</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Perchlorate and nitrate remediation efficiency and microbial diversity in a containerized wetland bioreactor</article-title>
          <source>Int J Phytoremediat</source>
          <year>2005</year>
          <volume>7</volume>
          <fpage>113</fpage>
          <lpage>128</lpage>
          <pub-id pub-id-type="doi">10.1080/16226510590950414</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Krauter P, Daily B Jr, Dibley V, Pinkart H, Legler T (2005) Perchlorate and nitrate remediation efficiency and microbial diversity in a containerized wetland bioreactor. Int J Phytoremediat 7:113&#x2013;128 </citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andreoni</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Cavalca</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Nocerino</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bernasconi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dell&#x2019;Amico</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Colombo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gianfreda</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Bacterial communities and enzyme activities of PAHs polluted soils</article-title>
          <source>Chemosphere</source>
          <year>2004</year>
          <volume>57</volume>
          <fpage>401</fpage>
          <lpage>412</lpage>
          <pub-id pub-id-type="doi">10.1016/j.chemosphere.2004.06.013</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Andreoni V, Cavalca L, Rao MA, Nocerino G, Bernasconi S, Dell&#x2019;Amico E, Colombo M, Gianfreda L (2004) Bacterial communities and enzyme activities of PAHs polluted soils. Chemosphere 57:401&#x2013;412 <pub-id pub-id-type="pmid">15331267</pub-id></citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vinas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sabate</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Espuny</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Solanas</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Bacterial community dynamics and polycyclic aromatic hydrocarbon degradation during bioremediation of heavily creosote-contaminated soil</article-title>
          <source>Appl Environ Microbiol</source>
          <year>2005</year>
          <volume>71</volume>
          <fpage>7008</fpage>
          <lpage>7018</lpage>
          <pub-id pub-id-type="doi">10.1128/AEM.71.11.7008-7018.2005</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Vinas M, Sabate J, Espuny MJ, Solanas AM (2005) Bacterial community dynamics and polycyclic aromatic hydrocarbon degradation during bioremediation of heavily creosote-contaminated soil. Appl Environ Microbiol 71:7008&#x2013;7018 <pub-id pub-id-type="pmid">16269736</pub-id></citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koning</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Diallinas</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Nucleobase transporters (review)</article-title>
          <source>Mol Membr Biol</source>
          <year>2000</year>
          <volume>17</volume>
          <fpage>75</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="doi">10.1080/09687680050117101</pub-id>
        </citation>
        <citation citation-type="display-unstructured">de Koning H, Diallinas G (2000) Nucleobase transporters (review). Mol Membr Biol 17:75&#x2013;94 <pub-id pub-id-type="pmid">10989458</pub-id></citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amillis</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cecchetto</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Sophianopoulou</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Koukaki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Scazzocchio</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Diallinas</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Transcription of purine transporter genes is activated during the isotropic growth phase of <italic>Aspergillus nidulans</italic> conidia</article-title>
          <source>Mol Microbiol</source>
          <year>2004</year>
          <volume>52</volume>
          <fpage>205</fpage>
          <lpage>216</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03956.x</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Amillis S, Cecchetto G, Sophianopoulou V, Koukaki M, Scazzocchio C, Diallinas G (2004) Transcription of purine transporter genes is activated during the isotropic growth phase of Aspergillus nidulans conidia. Mol Microbiol 52:205&#x2013;216 <pub-id pub-id-type="pmid">15049821</pub-id></citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cecchetto</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Amillis</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Diallinas</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Scazzocchio</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Drevet</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>The AzgA purine transporter of <italic>Aspergillus nidulans</italic>. Characterization of a protein belonging to a new phylogenetic cluster</article-title>
          <source>J Biol Chem</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>3132</fpage>
          <lpage>3141</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M308826200</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Cecchetto G, Amillis S, Diallinas G, Scazzocchio C, Drevet C (2004) The AzgA purine transporter of Aspergillus nidulans. Characterization of a protein belonging to a new phylogenetic cluster. J Biol Chem 279:3132&#x2013;3141 <pub-id pub-id-type="pmid">14597637</pub-id></citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vogels</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Drift</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Degradation of purines and pyrimidines by microorganisms</article-title>
          <source>Bacteriol Rev</source>
          <year>1976</year>
          <volume>40</volume>
          <fpage>403</fpage>
          <lpage>468</lpage>
        </citation>
        <citation citation-type="display-unstructured">Vogels GD, Van der Drift C (1976) Degradation of purines and pyrimidines by microorganisms. Bacteriol Rev 40:403&#x2013;468 <pub-id pub-id-type="pmid">786256</pub-id></citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scazzocchio</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>The purine degradation pathway, genetics, biochemistry and regulation</article-title>
          <source>Prog Ind Microbiol</source>
          <year>1994</year>
          <volume>29</volume>
          <fpage>221</fpage>
          <lpage>257</lpage>
        </citation>
        <citation citation-type="display-unstructured">Scazzocchio C (1994) The purine degradation pathway, genetics, biochemistry and regulation. Prog Ind Microbiol 29:221&#x2013;257 <pub-id pub-id-type="pmid">7765126</pub-id></citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burton</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Adenine transport in <italic>Escherichia coli</italic></article-title>
          <source>Proc Biol Sci</source>
          <year>1994</year>
          <volume>255</volume>
          <fpage>153</fpage>
          <lpage>157</lpage>
          <pub-id pub-id-type="doi">10.1098/rspb.1994.0022</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Burton K (1994) Adenine transport in Escherichia coli. Proc Biol Sci 255:153&#x2013;157 <pub-id pub-id-type="pmid">8165228</pub-id></citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koning</surname>
              <given-names>HP</given-names>
            </name>
            <name>
              <surname>Bridges</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Burchmore</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Purine and pyrimidine transport in pathogenic protozoa: from biology to therapy</article-title>
          <source>FEMS Microbiol Rev</source>
          <year>2005</year>
          <volume>29</volume>
          <fpage>987</fpage>
          <lpage>1020</lpage>
          <pub-id pub-id-type="doi">10.1016/j.femsre.2005.03.004</pub-id>
        </citation>
        <citation citation-type="display-unstructured">de Koning HP, Bridges DJ, Burchmore RJ (2005) Purine and pyrimidine transport in pathogenic protozoa: from biology to therapy. FEMS Microbiol Rev 29:987&#x2013;1020 <pub-id pub-id-type="pmid">16040150</pub-id></citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koning</surname>
              <given-names>HP</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Sutcliffe</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Jarvis</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Differential regulation of nucleoside and nucleobase transporters in <italic>Crithidia fasciculata</italic> and <italic>Trypanosoma brucei brucei</italic></article-title>
          <source>Mol Biochem Parasitol</source>
          <year>2000</year>
          <volume>106</volume>
          <fpage>93</fpage>
          <lpage>107</lpage>
          <pub-id pub-id-type="doi">10.1016/S0166-6851(99)00203-0</pub-id>
        </citation>
        <citation citation-type="display-unstructured">de Koning HP, Watson CJ, Sutcliffe L, Jarvis SM (2000) Differential regulation of nucleoside and nucleobase transporters in Crithidia fasciculata and Trypanosoma brucei brucei. Mol Biochem Parasitol 106:93&#x2013;107 <pub-id pub-id-type="pmid">10743614</pub-id></citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alleman</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Gottlieb</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Enhanced acquisition of purine nucleosides and nucleobases by purine-starved <italic>Crithidia luciliae</italic></article-title>
          <source>Mol Biochem Parasitol</source>
          <year>1996</year>
          <volume>76</volume>
          <fpage>279</fpage>
          <lpage>287</lpage>
          <pub-id pub-id-type="doi">10.1016/0166-6851(96)02566-2</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Alleman MM, Gottlieb M (1996) Enhanced acquisition of purine nucleosides and nucleobases by purine-starved Crithidia luciliae. Mol Biochem Parasitol 76:279&#x2013;287 <pub-id pub-id-type="pmid">8920013</pub-id></citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beaman</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Hitchins</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Ochi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vasantha</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Endo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Freese</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Specificity and control of uptake of purines and other compounds in <italic>Bacillus subtilis</italic></article-title>
          <source>J Bacteriol</source>
          <year>1983</year>
          <volume>156</volume>
          <fpage>1107</fpage>
          <lpage>1117</lpage>
        </citation>
        <citation citation-type="display-unstructured">Beaman TC, Hitchins AD, Ochi K, Vasantha N, Endo T, Freese E (1983) Specificity and control of uptake of purines and other compounds in Bacillus subtilis. J Bacteriol 156:1107&#x2013;1117 <pub-id pub-id-type="pmid">6417108</pub-id></citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nygaard</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Duckert</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Saxild</surname>
              <given-names>HH</given-names>
            </name>
          </person-group>
          <article-title>Role of adenine deaminase in purine salvage and nitrogen metabolism and characterization of the <italic>ade</italic> gene in <italic>Bacillus subtilis</italic></article-title>
          <source>J Bacteriol</source>
          <year>1996</year>
          <volume>178</volume>
          <fpage>846</fpage>
          <lpage>853</lpage>
        </citation>
        <citation citation-type="display-unstructured">Nygaard P, Duckert P, Saxild HH (1996) Role of adenine deaminase in purine salvage and nitrogen metabolism and characterization of the ade gene in Bacillus subtilis. J Bacteriol 178:846&#x2013;853 <pub-id pub-id-type="pmid">8550522</pub-id></citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cabrita</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Baldwin</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Cass</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <article-title>Molecular biology and regulation of nucleoside and nucleobase transporter proteins in eukaryotes and prokaryotes</article-title>
          <source>Biochem Cell Biol</source>
          <year>2002</year>
          <volume>80</volume>
          <fpage>623</fpage>
          <lpage>638</lpage>
          <pub-id pub-id-type="doi">10.1139/o02-153</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Cabrita MA, Baldwin SA, Young JD, Cass CE (2002) Molecular biology and regulation of nucleoside and nucleobase transporter proteins in eukaryotes and prokaryotes. Biochem Cell Biol 80:623&#x2013;638 <pub-id pub-id-type="pmid">12440702</pub-id></citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Griffith</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Jarvis</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Characterization of a sodium-dependent concentrative nucleobase-transport system in guinea-pig kidney cortex brush-border membrane vesicles</article-title>
          <source>Biochem J</source>
          <year>1994</year>
          <volume>303</volume>
          <fpage>901</fpage>
          <lpage>905</lpage>
        </citation>
        <citation citation-type="display-unstructured">Griffith DA, Jarvis SM (1994) Characterization of a sodium-dependent concentrative nucleobase-transport system in guinea-pig kidney cortex brush-border membrane vesicles. Biochem J 303:901&#x2013;905 <pub-id pub-id-type="pmid">7980460</pub-id></citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Griffith</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Jarvis</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Nucleoside and nucleobase transport systems of mammalian cells</article-title>
          <source>Biochim Biophys Acta</source>
          <year>1996</year>
          <volume>1286</volume>
          <fpage>153</fpage>
          <lpage>181</lpage>
        </citation>
        <citation citation-type="display-unstructured">Griffith DA, Jarvis SM (1996) Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1286:153&#x2013;181 <pub-id pub-id-type="pmid">8982282</pub-id></citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burkle</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Cedzich</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dopke</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Stransky</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Okumoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gillissen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kuhn</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Frommer</surname>
              <given-names>WB</given-names>
            </name>
          </person-group>
          <article-title>Transport of cytokinins mediated by purine transporters of the PUP family expressed in phloem, hydathodes, and pollen of <italic>Arabidopsis</italic></article-title>
          <source>Plant J</source>
          <year>2003</year>
          <volume>34</volume>
          <fpage>13</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-313X.2003.01700.x</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Burkle L, Cedzich A, Dopke C, Stransky H, Okumoto S, Gillissen B, Kuhn C, Frommer WB (2003) Transport of cytokinins mediated by purine transporters of the PUP family expressed in phloem, hydathodes, and pollen of Arabidopsis. Plant J 34:13&#x2013;26 <pub-id pub-id-type="pmid">12662305</pub-id></citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hyde</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Cass</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Baldwin</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms</article-title>
          <source>Mol Membr Biol</source>
          <year>2001</year>
          <volume>18</volume>
          <fpage>53</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="doi">10.1080/09687680110033765</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Hyde RJ, Cass CE, Young JD, Baldwin SA (2001) The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol 18:53&#x2013;63 <pub-id pub-id-type="pmid">11396612</pub-id></citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roy-Burman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Visser</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>Transport of purines and deoxyadenosine in <italic>Escherichia coli</italic></article-title>
          <source>J Biol Chem</source>
          <year>1975</year>
          <volume>250</volume>
          <fpage>9270</fpage>
          <lpage>9275</lpage>
        </citation>
        <citation citation-type="display-unstructured">Roy-Burman S, Visser DW (1975) Transport of purines and deoxyadenosine in Escherichia coli. J Biol Chem 250:9270&#x2013;9275 <pub-id pub-id-type="pmid">1104620</pub-id></citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn>
        <p>Anke C. Schiedel and Heiko Meyer contributed equally to this work.</p>
      </fn>
    </fn-group>
  </back>
</article>
</pmc-articleset>